Sun Pharma Advanced Research Company Limited
NSE:SPARC.NS
Overview | Financials
Company Name | Sun Pharma Advanced Research Company Limited |
Symbol | SPARC.NS |
Currency | INR |
Price | 207.44 |
Market Cap | 67,318,843,680 |
Dividend Yield | 0% |
52-week-range | 196.1 - 472.8 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Anilkumar Raghavan |
Website | https://www.sparc.life |
An error occurred while fetching data.
About Sun Pharma Advanced Research Company Limited
Sun Pharma Advanced Research Company Limited, a biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops new chemical and biological entities, and reformulated products with a therapeutic focus on oncology, neurodegeneration, ophthalmology, and dermatology. The company offers Elepsia, a formulation of levetiracetam
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD